{"vid":"V831","name":"p25_spy","file_id":"F1","var_intrvl":"discrete","var_width":"43","labl":"P25. Other (Specify)","var_respunit":"The post abortion care healthcare provider to the woman receiving treatment for abortion complications, the type of treatment received for complications, and the delays in access to post-abortion care","var_qstn_preqtxt":"N\/A","var_qstn_qstnlit":"Other (Specify)","var_qstn_postqtxt":"N\/A","var_qstn_ivulnstr":"N\/A","var_universe":"Healthcare provider","universe_clusion":"I","var_sumstat":[{"value":"10","type":"vald"},{"value":"0","type":"invd"}],"var_txt":"other specific uterotonics that was given to the patient","var_catgry":[{"value":"Cyntocinon 10iu in 500ml normal saline.","labl":null,"stats":"1","type":"freq"},{"value":"Methotrexate","labl":null,"stats":"1","type":"freq"},{"value":"Oxytocin","labl":null,"stats":"2","type":"freq"},{"value":"Oxytocin 10 I.u in 500 mls of normal saline","labl":null,"stats":"1","type":"freq"},{"value":"Sterons\/primulas N","labl":null,"stats":"1","type":"freq"},{"value":"Tranexaemic acid","labl":null,"stats":"1","type":"freq"},{"value":"Tranexamic acid","labl":null,"stats":"3","type":"freq"}],"var_format":"character","var_format_schema":"other","fid":"F1","sid":"188","survey_idno":"DDI-KEN-APHRC-KAS-PMS-2022-v1.0"}